TWIST BIOSCIENCE CORPORATION

(TWST)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Twist Bioscience, Revelar Say Data Show RBT-0813 Neutralizes Omicron, Delta Covid-19 Variants

01/05/2022 | 09:28am EDT


© MT Newswires 2022
All news about TWIST BIOSCIENCE CORPORATION
05/24INSIDER SELL : Twist Bioscience
MT
05/23TRANSCRIPT : Twist Bioscience Corporation Presents at UBS Global Healthcare Conference, Ma..
CI
05/18Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference
BU
05/12Certain Common Stock of Twist Bioscience Corporation are subject to a Lock-Up Agreement..
CI
05/12Certain Stock options of Twist Bioscience Corporation are subject to a Lock-Up Agreemen..
CI
05/12Certain Restricted Stock Units of Twist Bioscience Corporation are subject to a Lock-Up..
CI
05/11Miroculus, Inc. Optimizes Automated Next Generation Sequencing Library Preparation with..
CI
05/10Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting an..
BU
05/09Twist Bioscience Signs Research Collaboration, Exclusive Option License Deal With Astel..
MT
05/09JPMorgan Adjusts Price Target for Twist Bioscience to $30 From $65, Maintains Underweig..
MT
More news
Analyst Recommendations on TWIST BIOSCIENCE CORPORATION
More recommendations
Financials (USD)
Sales 2022 196 M - -
Net income 2022 -253 M - -
Net cash 2022 229 M - -
P/E ratio 2022 -7,34x
Yield 2022 -
Capitalization 1 953 M 1 953 M -
EV / Sales 2022 8,78x
EV / Sales 2023 7,03x
Nbr of Employees 652
Free-Float 91,4%
Chart TWIST BIOSCIENCE CORPORATION
Duration : Period :
Twist Bioscience Corporation Technical Analysis Chart | TWST | US90184D1000 | MarketScreener
Technical analysis trends TWIST BIOSCIENCE CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 34,72 $
Average target price 40,50 $
Spread / Average Target 16,6%
EPS Revisions
Managers and Directors
Emily Marine Leproust Chairman, President & Chief Executive Officer
James M. Thorburn Chief Financial Officer
Aaron K. Sato Chief Scientific Officer
Siyuan Chen Chief Technology Officer
Nimisha Srivastava Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
TWIST BIOSCIENCE CORPORATION-54.55%1 979